What are the major opportunities in the Leukapheresis market? What are the strategies for the Leukapheresis market?

For detailed insights on the major opportunities and strategies in the Leukapheresis market, Read More

How does the Leukapheresis market relate to the overall economy and other similar markets?

For detailed insights on Leukapheresis's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Leukapheresis market growth? SWOT analysis of the Leukapheresis market.

For detailed insights on the key dynamics influencing the Leukapheresis market growth and SWOT analysis of the Leukapheresis industry, Read More

Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Leukapheresis Global Market Report 2025

Name: Leukapheresis Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis ), By Product (Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables ), By Application (Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications), By End User (Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Leukapheresis Market Overview

• Leukapheresis market size has reached to $66.8 billion in 2024

• Expected to grow to $97.11 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%

• Growth Driver: Increasing Prevalence Of Autoimmune Diseases Driving Market Growth Through Targeted Treatment Innovations

• Market Trend: Advancing Cell Therapy Through High-Quality, Regulatory-Compliant Starting Materials

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Leukapheresis Market?

Leukapheresis is a medical procedure that involves separating and removing white blood cells (leukocytes) from a person's blood. The remaining components, such as red blood cells and plasma, are then returned to the body. This technique is used to treat conditions involving high white blood cell counts or to collect specific immune cells for research or therapy.

The main types of leukapheresis are granulocyte, lymphocyte, and monocyte apheresis. Granulocyte apheresis is a procedure that selectively separates granulocytes (a type of white blood cell) from a patient's blood for therapeutic use. Products include leukapheresis devices, centrifugal devices, membrane separators, and leukapheresis disposables. Applications span across research applications, cancer research, immunology research, therapeutic applications, hematologic disorders, autoimmune diseases, and others, and are used by blood component providers and blood centers, academic and research institutes, pharmaceutical and biotechnology companies, and hospitals and transfusion centers.

Leukapheresis Market Size and growth rate 2025 to 2029: Graph

What Is The Leukapheresis Market Size 2025 And Growth Rate?

What Is The Leukapheresis Market Growth Forecast?

The leukapheresis market size is expected to see strong growth in the next few years. It will grow to $97.11 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising demand for personalized cell therapies, increasing clinical trials in immuno-oncology, growing adoption in regenerative medicine, expansion of biopharmaceutical manufacturing, improved reimbursement policies, and greater awareness of cell-based research and treatment options. Major trends in the forecast period include improved cell separation technologies, integration of AI for procedure optimization, development of portable leukapheresis devices, advancements in cell and gene therapy, enhanced donor screening methods, and adoption of cloud-based data tracking systems.

The forecast of 7.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. cell therapy centers by increasing the cost of apheresis collection kits and leukocyte separation systems sourced from Germany and Sweden, thereby delaying chimeric antigen receptor t-cell therapy and stem cell therapies and elevating immunotherapy expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Leukapheresis Market Segmented?

1) By Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis

2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables

3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications

4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers

Subsegments:

1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis

2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis

3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes

What Is Driving The Leukapheresis Market? Increasing Prevalence Of Autoimmune Diseases Driving Market Growth Through Targeted Treatment Innovations

The rise of autoimmune diseases is expected to propel the growth of the leukapheresis market going forward. Autoimmune diseases refer to conditions where the immune system mistakenly attacks the body’s own healthy tissues. Reduced early-life microbial exposure and modern environmental factors are disrupting immune balance, leading to more autoimmune disorders. Leukapheresis helps treat autoimmune diseases by selectively removing harmful white blood cells that contribute to the immune system attacking the body's own tissues. For instance, in November 2024, according to the Versorgungsatlas.de, a Germany-based organization, in 2022, among 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a raw prevalence rate of 8.61%. Therefore, the rise of autoimmune diseases is driving the growth of the leukapheresis industry.

Who Are The Major Players In The Global Leukapheresis Market?

Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., STEMCELL Technologies Inc., Haemonetics Corporation, Macopharma, Discovery Life Sciences, BioIVT LLC, StemExpress LLC, MEDICA S.p.A, AllCells LLC, Caltag Medsystems Ltd., Miltenyi Biotec, Immune Therapy Holdings AB, Cellsep Laboratories, Accegen Biotec, Key Biologics LLC, HemaCare Corporation, Puriblood Medical, Cytopheron Technologies, Adacyte Therapeutics.

What Are The Key Trends Of The Global Leukapheresis Market? Advancing Cell Therapy Through High-Quality, Regulatory-Compliant Starting Materials

Major companies operating in the leukapheresis market are focusing on advancements such as developing GMP-grade leukopaks to enhance the quality and efficiency of cell therapy manufacturing. GMP-grade leukopaks are leukapheresis-derived products processed under stringent good manufacturing practice (GMP) standards, ensuring high viability and functionality of collected cells for therapeutic applications. For instance, in November 2024, Sanguine Biosciences, a US-based biotechnology company, launched LeukoCer, a GMP-grade leukopak designed to streamline workflows and accelerate cell therapy development. LeukoCert offers high-quality starting materials available in fresh whole or half packs, produced according to strict GMP standards, thereby empowering researchers to advance their research and bring new cell therapies to market faster.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Leukapheresis Market? SCTbio And Cyto-care.eu GmbH Partner To Advance Cryopreservation For Cell Therapy In Europe

In July 2023, SCTbio, a Czech Republic-based contract development and manufacturing organization, partnered with Cyto-care.eu GmbH to enhance the cryopreservation process for cell therapy in Europe. Their partnership specifically targets improving the collection, cryopreservation, quality control, and logistics of leukapheresis materials, which are critical components in the manufacturing of advanced cell therapy products (ATMPs). Cyto-Care.eu GmbH is an Austria-based company specializing in providing cell products for biomedical research, drug discovery, and cell and gene therapy.

What Is The Regional Outlook For The Global Leukapheresis Market?

North America was the largest region in the leukapheresis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Leukapheresis Market?

The leukapheresis market consists of revenues earned by entities providing services such as cell collection, cell processing and storage, and custom apheresis procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The leukapheresis market also includes sales of products such as apheresis machines, centrifugal and membrane-based systems, needles & catheters, and anticoagulants and solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Leukapheresis Industry?

The leukapheresis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the leukapheresis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Leukapheresis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$72.02 billion
Revenue Forecast In 2034	$97.11 billion
Growth Rate	CAGR of 7.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The leukapheresis market covered in this report is segmented – 1) By Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis 2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables 3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications 4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers Subsegments: 1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis 2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis 3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., STEMCELL Technologies Inc., Haemonetics Corporation, Macopharma, Discovery Life Sciences, BioIVT LLC, StemExpress LLC, MEDICA S.p.A, AllCells LLC, Caltag Medsystems Ltd., Miltenyi Biotec, Immune Therapy Holdings AB, Cellsep Laboratories, Accegen Biotec, Key Biologics LLC, HemaCare Corporation, Puriblood Medical, Cytopheron Technologies, Adacyte Therapeutics.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Leukapheresis Market Characteristics

3. Leukapheresis Market Trends And Strategies

4. Leukapheresis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Leukapheresis Growth Analysis And Strategic Analysis Framework

5.1. Global Leukapheresis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Leukapheresis Market Growth Rate Analysis

5.4. Global Leukapheresis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Leukapheresis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Leukapheresis Total Addressable Market (TAM)

6. Leukapheresis Market Segmentation

6.1. Global Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Granulocyte Apheresis

Lymphocyte Apheresis

Monocyte Apheresis

6.2. Global Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Leukapheresis Devices

Centrifugal Devices

Membrane Separators

Leukapheresis Disposables

6.3. Global Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Research Application

Cancer Research

Immunology Research

Therapeutics Application

Hematologic Disorders

Autoimmune Diseases

Other Applications

6.4. Global Leukapheresis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Blood Component Providers And Blood Centers

Academic And Research Institutes

Pharmaceutical And Biotechnology Companies

Hospitals And Transfusion Centers

6.5. Global Leukapheresis Market, Sub-Segmentation Of Granulocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Neutrophil Apheresis

Eosinophil Apheresis

Basophil Apheresis

6.6. Global Leukapheresis Market, Sub-Segmentation Of Lymphocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

T-Cell Apheresis

B-Cell Apheresis

Natural Killer (NK) Cell Apheresis

6.7. Global Leukapheresis Market, Sub-Segmentation Of Monocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Classical Monocytes

Non-Classical Monocytes

Intermediate Monocytes

7. Leukapheresis Market Regional And Country Analysis

7.1. Global Leukapheresis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Leukapheresis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Leukapheresis Market

8.1. Asia-Pacific Leukapheresis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Leukapheresis Market

9.1. China Leukapheresis Market Overview

9.2. China Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Leukapheresis Market

10.1. India Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Leukapheresis Market

11.1. Japan Leukapheresis Market Overview

11.2. Japan Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Leukapheresis Market

12.1. Australia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Leukapheresis Market

13.1. Indonesia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Leukapheresis Market

14.1. South Korea Leukapheresis Market Overview

14.2. South Korea Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Leukapheresis Market

15.1. Western Europe Leukapheresis Market Overview

15.2. Western Europe Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Leukapheresis Market

16.1. UK Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Leukapheresis Market

17.1. Germany Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Leukapheresis Market

18.1. France Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Leukapheresis Market

19.1. Italy Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Leukapheresis Market

20.1. Spain Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Leukapheresis Market

21.1. Eastern Europe Leukapheresis Market Overview

21.2. Eastern Europe Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Leukapheresis Market

22.1. Russia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Leukapheresis Market

23.1. North America Leukapheresis Market Overview

23.2. North America Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Leukapheresis Market

24.1. USA Leukapheresis Market Overview

24.2. USA Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Leukapheresis Market

25.1. Canada Leukapheresis Market Overview

25.2. Canada Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Leukapheresis Market

26.1. South America Leukapheresis Market Overview

26.2. South America Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Leukapheresis Market

27.1. Brazil Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Leukapheresis Market

28.1. Middle East Leukapheresis Market Overview

28.2. Middle East Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Leukapheresis Market

29.1. Africa Leukapheresis Market Overview

29.2. Africa Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Leukapheresis Market Competitive Landscape And Company Profiles

30.1. Leukapheresis Market Competitive Landscape

30.2. Leukapheresis Market Company Profiles

30.2.1. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Terumo BCT Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Nikkiso Co. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Leukapheresis Market Other Major And Innovative Companies

31.1. Haemonetics Corporation

31.2. Macopharma

31.3. Discovery Life Sciences

31.4. BioIVT LLC

31.5. StemExpress LLC

31.6. MEDICA S.p.A

31.7. AllCells LLC

31.8. Caltag Medsystems Ltd.

31.9. Miltenyi Biotec

31.10. Immune Therapy Holdings AB

31.11. Cellsep Laboratories

31.12. Accegen Biotec

31.13. Key Biologics LLC

31.14. HemaCare Corporation

31.15. Puriblood Medical

32. Global Leukapheresis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leukapheresis Market

34. Recent Developments In The Leukapheresis Market

35. Leukapheresis Market High Potential Countries, Segments and Strategies

35.1 Leukapheresis Market In 2029 - Countries Offering Most New Opportunities

35.2 Leukapheresis Market In 2029 - Segments Offering Most New Opportunities

35.3 Leukapheresis Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Leukapheresis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Leukapheresis Market, Sub-Segmentation Of Granulocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Leukapheresis Market, Sub-Segmentation Of Lymphocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Leukapheresis Market, Sub-Segmentation Of Monocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Leukapheresis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Leukapheresis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Fresenius Kabi Financial Performance

Table 79: Grifols S.A. Financial Performance

Table 80: Terumo BCT Inc. Financial Performance

Table 81: Nikkiso Co. Financial Performance

Table 82: STEMCELL Technologies Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Leukapheresis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Leukapheresis Market, Sub-Segmentation Of Granulocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Leukapheresis Market, Sub-Segmentation Of Lymphocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Leukapheresis Market, Sub-Segmentation Of Monocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Leukapheresis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Leukapheresis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Fresenius Kabi Financial Performance

Figure 79: Grifols S.A. Financial Performance

Figure 80: Terumo BCT Inc. Financial Performance

Figure 81: Nikkiso Co. Financial Performance

Figure 82: STEMCELL Technologies Inc. Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Leukemia Therapeutics Global Market Report 2025 – By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments), By Type Of Leukemia (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymp...

Chronic Myeloid Leukemia Treatment Global Market Report 2025 – By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Route of Administration (Oral, Parenteral, Other Route of ...

Anaplastic Astrocytoma Global Market Report 2025 – By Disease Type (Grade I, Grade II, Grade III, Grade IV), By Treatment Type (Surgery, Chemotherapy, Radiation), By Treatment Phase (Pre-Registration Phase, Clinical Tria...

Chronic Lymphocytic Leukemia Treatment Global Market Report 2025 – By Type (Aggressive CLL, Indolent CLL, Other Types), By Treatment (Targeted Drug Therapy, Chemotherapy, Bone Marrow Transplant, Immunotherapy), By Route ...

Lenalidomide Global Market Report 2025 – By Type (5Mg Capsules, 10Mg Capsules, 15Mg Capsules, 25Mg Capsules), By Application (Multiple Myeloma (MM), Myelodysplastic Syndromes (MDS), Lymphoma, Other Applications), By End-...

Xerostomia Therapeutics Global Market Report 2025 – By Type (Artificial Saliva Or Saliva Substitutes, Salivary Stimulants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmac...

Cell Therapy Global Market Report 2025 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous ...

Frequently Asked Questions

What is the definition of the Leukapheresis market?

How will the Leukapheresis market drivers and restraints affect the market dynamics? What forces will shape the Leukapheresis industry going forward?

The market major growth driver - Increasing Prevalence Of Autoimmune Diseases Driving Market Growth Through Targeted Treatment Innovations. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Leukapheresis market?

The leukapheresis market size has grown strongly in recent years. It will grow from $66.8 billion in 2024 to $72.02 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing prevalence of leukemia and autoimmune diseases, rising demand for personalized medicine, growth in stem cell research, improvements in apheresis technologies, expanding clinical trial activities, and greater awareness of immunotherapy applications. The leukapheresis market size is expected to see strong growth in the next few years. It will grow to " $97.11 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising demand for personalized cell therapies, increasing clinical trials in immuno-oncology, growing adoption in regenerative medicine, expansion of biopharmaceutical manufacturing, improved reimbursement policies, and greater awareness of cell-based research and treatment options. Major trends in the forecast period include improved cell separation technologies, integration of AI for procedure optimization, development of portable leukapheresis devices, advancements in cell and gene therapy, enhanced donor screening methods, and adoption of cloud-based data tracking systems. For further insights on this market, request a sample here

How is the Leukapheresis market segmented?

The leukapheresis market covered in this report is segmented –
1) By Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis
2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables
3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications
4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers Subsegments:
1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis
2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis
3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes For further insights on this market, request a sample here

Which region has the largest share of the Leukapheresis market? What are the other regions covered in the report?

North America was the largest region in the leukapheresis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Leukapheresis market?

What are the key trends in the Leukapheresis market?

Major trends in this market include Advancing Cell Therapy Through High-Quality, Regulatory-Compliant Starting Materials. For further insights on this market, request a sample here.